Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Alivexis, Inc logo — Delivering the future of medicines

Alivexis, Inc

Delivering the future of medicines

Founded 2016 Japan Japan 12 employees Series C Biotechnology, Pharmaceutical

General Information

Company Name Alivexis, Inc
Founded Year 2016
Location Japan Japan
Employees 12
Industries Biotechnology, Pharmaceutical
Funding Stage Series C
Business Model B2B, Platform
Revenue Model Licensing, Project Based, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Alivexis, Inc. To contact Alivexis, Inc, visit alivexis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Alivexis, Inc compare?

A PDF of Alivexis, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Alivexis, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Alivexis, Inc

Alivexis, Inc, previously known as Modulus Discovery, Inc, is actively carving a niche in the biotechnology and pharmaceutical industries. The company, founded in 2016, operates from its headquarters in Japan while maintaining a significant presence in the United States.

With the slogan “Delivering the future of medicines,” Alivexis, Inc is distinguished by its fusion of cutting-edge drug discovery platforms with exceptional disease biology expertise. The company is advancing a unique portfolio of small molecule drugs. Additionally, it engages in a variety of research and development collaborations, reflecting its dynamic global business strategy.

Although Alivexis, Inc does not report recent investments or investor partnerships, its strategic positioning and innovative approach signal potential for substantial future investment opportunities, ideal for investors seeking to penetrate the forefront of pharmaceutical innovations.

Business keywords: Drug Discovery, Small Molecule Drugs, Preclinical Stage, Computational Drug Discovery, Disease Biology, Biopharmaceuticals, R&D Collaborations, Pharmaceutical Expertise, Global Business Approach, Innovative Research, Technology-driven

Services & Products

Research and development of small-molecule targeted therapeutics
Integration of biology insights with technology
Accelerated delivery of therapeutic candidates

Target Customers

Patients and families in need Pharmaceutical companies Biotechnology researchers Healthcare providers

No funding data available for Alivexis, Inc yet.

Alivexis, Inc Alternatives & Competitors

View All Alternatives
Alivexis, Inc vs
Modulus Discovery
Modulus Discovery

Advancing the future of medicine by harnessing innovative computational drug discovery and profound...

Series D
2 employees
Biotechnology, Care Economy
Alivexis, Inc vs
Sharp Therapeutics
Sharp Therapeutics United States

Developing small molecule drugs for genetic diseases..

10 employees
Biopharma, Biotechnology
Alivexis, Inc vs
Frontier Medicines
Frontier Medicines United States

Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transform patients...

Series C
80 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Alivexis, Inc

Delivering the future of medicines
Alivexis, Inc was founded in 2016.
Alivexis, Inc is headquartered in Japan.
Alivexis, Inc operates in Biotechnology and Pharmaceutical. Its work centres on Drug Discovery, Small Molecule Drugs, Preclinical Stage and Computational Drug Discovery. Its customers include Patients and families in need, Pharmaceutical companies and Biotechnology researchers.
Alivexis, Inc has a B2B and Platform business model. Its revenue comes from Licensing, Project Based and Product Sales.
Alivexis, Inc has approximately 12 employees.
Alivexis, Inc offers: Research and development of small-molecule targeted therapeutics, Integration of biology insights with technology, Accelerated delivery of therapeutic candidates.
Top alternatives and competitors to Alivexis, Inc include Modulus Discovery, Sharp Therapeutics, Frontier Medicines, Astex Pharmaceuticals , Diffuse Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alivexis, Inc and Modulus Discovery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alivexis, Inc, https://bouncewatch.com/company/alivexis-inc, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout